EMEA-001523-PIP04-19
Key facts
Invented name |
Tremfya
|
Active substance |
guselkumab
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0461/2020
|
PIP number |
EMEA-001523-PIP04-19
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of ulcerative colitis
|
Route(s) of administration |
|
Contact for public enquiries |
Janssen-Cilag International N.V.
Tel. +32 14602111 |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|